Peer-reviewed research helps patients and families evaluate Anterior Scoliosis Correction (ASC) using objective clinical evidence rather than anecdote alone. Published studies allow outcomes, risks, and patient selection criteria to be reviewed in a transparent, standardized way.
This page includes peer-reviewed studies from recognized spine journals examining ASC and closely related motion-preserving techniques across different ages and curve types. ASC has been evaluated through multiple clinical series over time, providing insight into both short- and longer-term outcomes.
This study describes a modified Anterior Scoliosis Correction technique using a double screw-line construct and thoracic disc releases to treat severe scoliosis curves greater than 65 degrees in adolescents.
The report focuses on surgical technique and outcomes, noting that this approach can expand the indications for ASC in patients with large, rigid curves and shows promising correction with motion-preserving constructs compared to traditional vertebral body tethering (VBT).
For published >92% success results on immature, maturing, and mature patients:
This paper presents an overview of the ASC approach as a non-fusion option for scoliosis correction, detailing how the technique works, its theoretical advantages over traditional fusion (such as motion preservation and reduced risk of adjacent segment degeneration), and early clinical outcomes. It provides foundational context for why ASC may be considered in appropriately selected patients.
This study reports outcomes for a small cohort of young children ages 5–10 with early-onset scoliosis treated using ASC with intervertebral de-tethering releases. Over medium-term follow-up (~4 years), patients had substantial curve correction (average ~75 %), and some required additional procedures, but fusion was avoided in most. The findings suggest ASC may be a feasible non-fusion alternative in select early onset cases.
Yes. Peer-reviewed studies following patients for multiple years show that Anterior Scoliosis Correction provides durable curve correction while preserving spinal motion in properly selected patients. Published research tracks outcomes such as curve stability, complication rates, revision frequency, and functional measures, offering insight into how patients do beyond the initial recovery period.
While ASC is newer than traditional fusion, the growing body of longitudinal data continues to inform patient selection and expected outcomes.
Published research shows clear differences between ASC and metal rod spinal fusion. Metal Rod Spinal fusion reliably corrects curves but permanently limits motion in the fused segments. ASC studies highlight motion preservation, continued spinal growth in younger patients, and maintained flexibility, with correction achieved through tension rather than fusion.
Research also discusses differing risk profiles, recovery timelines, and revision considerations, emphasizing that ASC and fusion serve different patient populations rather than acting as interchangeable procedures.
ASC uses FDA-cleared surgical implants and instrumentation already approved for spinal use, applied in a motion-preserving manner rather than a fusion construct. While ASC itself is a surgical technique (not a standalone device), its regulatory considerations involve appropriate implant use, surgeon training, and patient selection.
Ongoing published research and post-market data help guide responsible clinical use within existing regulatory frameworks overseen by the U.S. Food and Drug Administration.
